Platine, Avastin and OLAparib in 1st Line

NCT02477644 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

806

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Olaparib
DRUG: Placebo

Sponsor

Arcagy Research

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]